| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |